Provider h1.location_city

The START Center for Cancer Research ("START") is the world's largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START's mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 45 therapies conducted at START locations have obtained FDA/EMA approval.

We are hiring an Advanced Practice Provider (APP) – Early Phase Clinical Research Program. The Advanced Practice Provider (APP) – Early Phase Clinical Research Program supports protocol-compliant patient care and clinical trial execution for Phase I and other early-phase oncology studies. Functioning as a sub-investigator under the supervision of the Principal Investigator (PI), the APP extends clinical capacity, supports screening and study visits, and enhances care coordination while preserving core investigator responsibilities specific to early-phase research.

Essential Responsibilities

• Serve as a sub-investigator on assigned early-phase clinical trials following completion of required training and delegation documentation.
• Conduct protocol-required physical examinations and study visits for patients in screening, on treatment, and in follow-up as delegated by the Principal Investigator.
• Prepare comprehensive medical histories and clinical summaries in advance of new patient consults to support efficient PI evaluation.
• Assist with screening activities prior to new patient visits, including preliminary chart review and protocol feasibility assessment.
• Support post-consent screening by assisting with protocol-specific screening questions and required clarifications.
• Assist with the identification, documentation, and follow-up of adverse events (AEs) and serious adverse events (SAEs) in collaboration with the Principal Investigator and research team.
• Attend sponsor or safety calls designated as low priority or routine, as delegated by the Principal Investigator.
• Act as the first point of clinical contact for the research care team for day-to-day patient management questions and escalate issues to the Principal Investigator as appropriate.
• Coordinate with nursing, pharmacy, clinical research coordinators, and data management to ensure safe, efficient, and protocol-adherent care delivery.
• Other duties may be assigned at any time.

Education & Experience

• Advanced practice degree (Nurse Practitioner or Physician Assistant) with current licensure in the applicable state(s).
• Minimum of 5 years of experience in oncology clinical care or oncology clinical research.

Preferred Education and Experience:

• Master's degree or Doctoral degree in advanced practice nursing or physician assistant studies.
• National certification as a Nurse Practitioner or Physician Assistant.
• Eligibility and willingness to serve as a sub-investigator on oncology clinical trials.
• Prior experience in early-phase (Phase I) oncology clinical research.

Physical & Travel Requirements:

• Travel: Limited travel may be required during training and onboarding.
• Sitting: Must be able to sit for extended periods of time.
• Standing: Must be able to stand for extended periods of time.
• Bending: Must be able to reach overhead, at shoulder level, or bend to perform tasks.
• Lifting: Must be able to lift up to 25 pounds.
• Exposure: Works closely with physicians, research staff, and ancillary personnel in caring for and treating oncology patients.

Ready to be part of a team changing the future of cancer treatment?

Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide. Please submit your application online.